Novel HIF2A mutations disrupt oxygen sensing, leading to polycythemia, paragangliomas, and somatostatinomas Blood, Mar 2013; 121: 2563 - 2566.
[anti-HA]
Regulation of the PI3-K/Akt Survival Pathway in the Rat Endometrium Biol Reprod, Mar 2013; 88: 79.
[Akt3]
RNA elements directing in vivo assembly of the 7SK/MePCE/Larp7 transcriptional regulatory snRNP Nucleic Acids Res., Mar 2013; 10.1093/nar/gkt159.
[LA]
Ruxolitinib as potential targeted therapy for patients with JAK2 rearrangements Haematologica, Mar 2013; 98: 404 - 408.
[JAK2]
Carcinoma antigen 125 (CA 125) is a high molecular weight tumor antigen that is the basis for a widely used serum assay for the monitoring of patients with ovarian epithelial cancer (1). It is a heavily glycosylated mucin expressed on the surface of ovarian tumor cells and on human MUC16, a cell surface bound mucin that is also shed by proteolytic cleavage (2, 3). Furthermore, MUC16 is a potent inhibitor of natural killer cell mediated anti-tumor cytotoxic responses (3). Binding of CA125 to membrane-bound mesothelin mediates heterotypic cell adhesion, which may contribute to the metastasis of ovarian cancer to the peritoneum by initiating cell attachment to the mesothelial epithelium (1).
Related Pathway
* Shipping is in business days
* OriGene provides validated application data and protocol, with money back guarantee.
